These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 28818347)

  • 1. Use of supplemental long-chain omega-3 fatty acids and risk for cardiac death: An updated meta-analysis and review of research gaps.
    Maki KC; Palacios OM; Bell M; Toth PP
    J Clin Lipidol; 2017; 11(5):1152-1160.e2. PubMed ID: 28818347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omega-3 free fatty acids for the treatment of severe hypertriglyceridemia: the EpanoVa fOr Lowering Very high triglyceridEs (EVOLVE) trial.
    Kastelein JJ; Maki KC; Susekov A; Ezhov M; Nordestgaard BG; Machielse BN; Kling D; Davidson MH
    J Clin Lipidol; 2014; 8(1):94-106. PubMed ID: 24528690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiating prescription omega-3-acid ethyl esters (P-OM3) from dietary-supplement omega-3 fatty acids.
    Brunton S; Collins N
    Curr Med Res Opin; 2007 May; 23(5):1139-45. PubMed ID: 17519081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of omega-3 fatty acids on coronary revascularization and cardiovascular events: a meta-analysis.
    Dinu M; Sofi F; Lotti S; Colombini B; Mattioli AV; Catapano AL; Casula M; Baragetti A; Wong ND; Steg PG; Ambrosio G
    Eur J Prev Cardiol; 2024 Nov; 31(15):1863-1875. PubMed ID: 38869144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of a unique omega-3 formulation on the correction of nutritional deficiency and its effects on cardiovascular disease risk factors in a randomized controlled VASCAZEN(®) REVEAL Trial.
    Shaikh NA; Yantha J; Shaikh S; Rowe W; Laidlaw M; Cockerline C; Ali A; Holub B; Jackowski G
    Mol Cell Biochem; 2014 Nov; 396(1-2):9-22. PubMed ID: 25185754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Meta-Analysis of Randomized Controlled Trials and Prospective Cohort Studies of Eicosapentaenoic and Docosahexaenoic Long-Chain Omega-3 Fatty Acids and Coronary Heart Disease Risk.
    Alexander DD; Miller PE; Van Elswyk ME; Kuratko CN; Bylsma LC
    Mayo Clin Proc; 2017 Jan; 92(1):15-29. PubMed ID: 28062061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PUFA for human health: diet or supplementation?
    Abete P; Testa G; Galizia G; Della-Morte D; Cacciatore F; Rengo F
    Curr Pharm Des; 2009; 15(36):4186-90. PubMed ID: 20041820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prescription Omega-3 Fatty Acid Products and Dietary Supplements Are Not Interchangeable.
    Hilleman D; Smer A
    Manag Care; 2016 Jan; 25(1):46-52. PubMed ID: 26882630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omega-3 polyunsaturated fatty acids supplementation and cardiovascular outcomes: do formulation, dosage, and baseline cardiovascular risk matter? An updated meta-analysis of randomized controlled trials.
    Casula M; Olmastroni E; Gazzotti M; Galimberti F; Zambon A; Catapano AL
    Pharmacol Res; 2020 Oct; 160():105060. PubMed ID: 32634581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of omega-3 carboxylic acids on lipoprotein particles and other cardiovascular risk markers in high-risk statin-treated patients with residual hypertriglyceridemia: a randomized, controlled, double-blind trial.
    Dunbar RL; Nicholls SJ; Maki KC; Roth EM; Orloff DG; Curcio D; Johnson J; Kling D; Davidson MH
    Lipids Health Dis; 2015 Sep; 14():98. PubMed ID: 26328624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effectiveness of ω-3 polyunsaturated fatty acid interventions during pregnancy on obesity measures in the offspring: an up-to-date systematic review and meta-analysis.
    Vahdaninia M; Mackenzie H; Dean T; Helps S
    Eur J Nutr; 2019 Oct; 58(7):2597-2613. PubMed ID: 30251019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statin Use Mitigate the Benefit of Omega-3 Fatty Acids Supplementation-A Meta-Regression of Randomized Trials.
    Sethi A; Bajaj A; Khosla S; Arora RR
    Am J Ther; 2016; 23(3):e737-48. PubMed ID: 25036814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic Bioavailability and Dose Proportionality of Omega-3 Administered in Free Fatty Acid Form Compared With Ethyl Ester Form: Results of a Phase 1 Study in Healthy Volunteers.
    Offman E; Davidson M; Abu-Rashid M; Chai P; Nilsson C
    Eur J Drug Metab Pharmacokinet; 2017 Oct; 42(5):815-825. PubMed ID: 28116646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel, multi-ingredient supplement to manage elevated blood lipids in patients with no evidence of cardiovascular disease: a pilot study.
    Hobbs T; Caso R; McMahon D; Nymark M
    Altern Ther Health Med; 2014; 20(5):18-23. PubMed ID: 25141367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of omega-3 fatty acids supplementation on insulin resistance in women with polycystic ovary syndrome: Meta-analysis of randomized controlled trials.
    Sadeghi A; Djafarian K; Mohammadi H; Shab-Bidar S
    Diabetes Metab Syndr; 2017; 11(2):157-162. PubMed ID: 27484441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of omega-3 carboxylic acids on apolipoprotein CIII-containing lipoproteins in severe hypertriglyceridemia.
    Morton AM; Furtado JD; Lee J; Amerine W; Davidson MH; Sacks FM
    J Clin Lipidol; 2016; 10(6):1442-1451.e4. PubMed ID: 27919362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary supplementation with eicosapentaenoic acid, but not with other long-chain n-3 or n-6 polyunsaturated fatty acids, decreases natural killer cell activity in healthy subjects aged >55 y.
    Thies F; Nebe-von-Caron G; Powell JR; Yaqoob P; Newsholme EA; Calder PC
    Am J Clin Nutr; 2001 Mar; 73(3):539-48. PubMed ID: 11237929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of High-Dose Marine Omega-3 Fatty Acids on Atherosclerosis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
    Sekikawa A; Cui C; Sugiyama D; Fabio A; Harris WS; Zhang X
    Nutrients; 2019 Oct; 11(11):. PubMed ID: 31671524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Similar eicosapentaenoic acid and docosahexaenoic acid plasma levels achieved with fish oil or krill oil in a randomized double-blind four-week bioavailability study.
    Yurko-Mauro K; Kralovec J; Bailey-Hall E; Smeberg V; Stark JG; Salem N
    Lipids Health Dis; 2015 Sep; 14():99. PubMed ID: 26328782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between Long Chain n-3 Polyunsaturated Fatty Acids and Autism Spectrum Disorder: Systematic Review and Meta-Analysis of Case-Control and Randomised Controlled Trials.
    Mazahery H; Stonehouse W; Delshad M; Kruger MC; Conlon CA; Beck KL; von Hurst PR
    Nutrients; 2017 Feb; 9(2):. PubMed ID: 28218722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.